- Building constructed by Aurobindo Pharma with a budget of Rs 80 Cr under CSR
- Harish Rao, Kishan Reddy, Erolla Srinivas among others graced the programme
IndiGlobal Bureau
Aurobindo Pharma Foundation (APF), the philanthropic and CSR arm of Aurobindo Pharma Ltd, has funded Rs. 80 Crores and built a state-of-the-art oncology block under Corporate Social Responsibility (CSR) in Redhills, Hyderabad for MNJ Institute of Oncology and State Cancer Institute. It was inaugurated by Thaneeru Harish Rao Garu, Minister for Finance & Health, Medical and Family Welfare, Telangana along with G. Kishan Reddy, Union Minister of Tourism, Culture and Development of North-Eastern Region on Sunday.
TSMSIDC Chairman Errolla Srinivas, Aurobindo Pharma MD Nithyananda Reddy, Health Secretary S.A.M Rizvi, MNJ Hospital Director Dr. Jayalatha and several other dignitaries were also present. This block was built by Aurobindo Pharma Foundation in an effort to help the hospital in its endeavor to provide quality cancer care at free of cost.
MNJ Institute of Oncology and State Cancer Institute is committed to providing free, multidisciplinary cancer care to patients. The tertiary care institute offers a comprehensive range of services, including surgery, radiotherapy, chemotherapy, and palliative care, to patients from Telangana and neighbouring states.
Aurobindo Pharma Foundation (APF) has come forward to lend supporting hand and constructed a state-of-the-art oncology block on 2 acres of government land with Rs 80 Crore fund of Corporate Social Responsibility. This new block will not only provide specialised and supportive services but also acts as a research centre.
This state-of-the-art facility span over 2,32,000 square feet and is composed with 8 floor (cellar, lower ground, ground + 5 floors) building with a total bed capacity of 300 and all floors are interconnected with staircase, ramp and lift with high end features such as 30 wardrooms, 2 operation theatres, 12 consultation rooms, 2 radiology bunkers, 8 bone marrow transplant rooms, dedicated paediatric and adolescent ICUs, diagnostic rooms (CT scan), microbiology and chemistry labs, besides a proper kitchen and dining rooms.
The Aurobindo Pharma Foundation (APF) also provided several facilities to ensure the smooth running of the facility, well equipped with oxygen pipelines and cylinders, ICU beds and curtains, furniture for doctor consultation rooms, waiting areas, fire safety systems (fire hydrant, sprinkler, public address systems and fire extinguishers), HVAC systems, lifts, emergency exits, transformer yard, main power control room and lightning arrestors.
Addressing the gathering, Harish Rao thanked Aurobindo Pharma for constructing a new building and handing it over to the government. The new block has increased the number of beds to 750, and the government has provided all the facilities at the hospital with 60 crores, he said.
Since the formation of Telangana, Rs 800 crores Aarogyasri funds were released just for cancer treatment. Last year, 137 crores was spent for cancer patients. Soon, chemotherapy and radiotherapy will be available in districts for cancer patients. The government will also do cancer detection through diagnostic centers, Harish informed.
K Nityananda Reddy, Director of Aurobindo Pharma Foundation and Managing Director & Vice Chairman, Aurobindo Pharma Ltd, said, The successful completion and handing over of Aurobindo Oncology block of the MNJ Hospital to the Govt of Telangana is a testament to our commitment to support infrastructure development in public health domain to aid needy communities. This is a major milestone in our journey as a healthcare organization to provide proper medical care and treatment for underprivileged patients. We are thankful to the Government of Telangana for their support in making this vision a reality.”
Potential Impact of the Facility as per the MNJ Officials:
- Every year, around 14,000 new patients seek treatment, and the daily average of outpatients is expected to be 600.
- It is anticipated that the annual follow-up patient count for treatment will exceed 1.50 lakh patients.
- The existing facility has 450 beds, and this new facility will add 300 more beds, increasing the total capacity.
- Features such as bone marrow transplant rooms, dedicated paediatric and adolescent wards, targeted radiotherapy will be enhanced.
- This facility will introduce genetics and molecular labs, aiding in diagnosis and treatment of the disease